Prolonged systemic delivery of tirofiban in a thrombus-laden saphenous vein graft

International Journal of Cardiovascular Interventions

Volumn 5, Issue 2, 2003, Pages 92-94

  Gruberg, Lius ^a,b   Amikam, Shlomo ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^b RAMBAM MEDICAL CENTER   (Israel)

Author keywords

Bypass surgery; Coronary anglioplasty; Thrombus; Tirofiban; Vein graft

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; LOW MOLECULAR WEIGHT HEPARIN; TIROFIBAN; TROPONIN T;

AGED; ANGIOCARDIOGRAPHY; ARTICLE; CASE REPORT; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DILATATION; GRAFT OCCLUSION; HEART LEFT BUNDLE BRANCH BLOCK; HEART MUSCLE ISCHEMIA; HUMAN; MALE; PRIORITY JOURNAL; SAPHENOUS VEIN GRAFT; THROMBUS;

AGED; CORONARY ARTERIOSCLEROSIS; CORONARY ARTERY BYPASS; FIBRINOLYTIC AGENTS; GRAFT OCCLUSION, VASCULAR; HUMANS; INFUSIONS, INTRAVENOUS; MALE; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; SAPHENOUS VEIN; THROMBOEMBOLISM; TYROSINE;

EID: 0037598680     PISSN: 14628848     EISSN: None     Source Type: Journal    
DOI: 10.1080/14628840304606     Document Type: Article

References (12)

1. Bourassa MG, Enjalbert M, Campeau L, Lesperance J. Progression of atherosclerosis in coronary arteries and bypass grafts: ten years later. Am J Cardiol 1984; 53: 102C-107C.
2. Fitzgibbon GM, Burton JR, Leach AJ. Coronary bypass graft fate: angiographic grading of 1400 consecutive grafts early after operation and 1132 after one year. Circulation 1978; 57: 1070-74.
3. Seides SF, Borer JS, Kent KM, Rosing DR, McIntosh CL, Epstein SE. Long-term anatomic fate of coronary artery bypass grafts and functional status of patients five years after operation. N Engl J Med 1978; 298: 1213-17.
4. Cameron A, Kemp HG, Green GE. Re-operation for coronary artery disease. Circulation 1988; 78(suppl I): 158-62.
5. Pidgeon J, Brooks N, Magee P, et al. Reoperation for angina after previous aortocoronary bypass surgery. Br Heart J 1985; 53: 269-75.
6. The EPIC Investigators. Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty. N Engl J Med 1994; 330: 956-61.
7. The EPILOG Investigators. Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization. N Engl J Med 1997; 336: 1689-96.
8. Mak KH, Challapalli R, Eisenberg MJ, Anderson KM, Califf RM, Topol EJ. Effect of platelet glycoprotein IIb/IIIa receptor inhibition on distal embolization during percutaneous revascularization of aortocoronary saphenous vein grafts. EPIC Investigators. Evaluation of IIb/IIIa platelet receptor antagonist 7E3 in Preventing Ischemic Complications. Am J Cardiol 1997; 80: 985-88.
9. Glazier JJ, Kierman FJ, Bauer HH, et al. Treatment of thrombotic saphenous vein grafts using local urokinase infusion therapy with the Dispatch catheter. Cathet Cardiovasc Diagn 1997; 41: 261-67.
10. Ambrose JA, Ameida OD, Sharma SK, et al, for the TAUSA investigators. Adjunctive thrombolytic therapy during angioplasty for ischemic rest angina: results of the TAUSA Trial. Circulation 1994; 90: 69-77.
11. Barsness GW, Buller C, Ohman EM, et al, for the Evaluation of the Dispatch Catheter for Vein Graft Revascularization (EDGE) Study. Reduced thrombus burden with abciximab delivered locally before percutaneous intervention in saphenous vein graft. Am Heart J 2000; 139: 824-29.
12. Robinson N, Barakat K, Dymond D. Platelet IIb/IIIa antagonists followed by delayed stent implantation. A new treatment for vein graft lesions containing massive thrombus. Heart 1999; 81: 434-37.